Abstract:Epilepsy Currents, Ahead of Print. Epilepsy-Associated SCN2A (NaV1.2) Variants Exhibit Diverse and Complex Functional Properties Thompson CH, Potet F, Abramova TV, DeKeyser JM, Ghabra NF, Vanoye CG, Millichap JJ, George AL. J Gen Physiol. 2023;155(10):e202313375. doi:10.1085/jgp.202313375. PMID: 37578743; PMCID: PMC10424433Pathogenic variants in neuronal voltage-gated sodium (NaV) channel genes including SCN2A, which encodes NaV1.2, are frequently discovered in neurodevelopmental disorders with and without epilepsy. SCN2A is also a high confidence risk gene for autism spectrum disorder (ASD) and nonsyndromic intellectual disability (ID). Previous work to determine the functional consequences of SCN2A variants yielded a paradigm in which predominantly gain-of-function (GoF) variants cause epilepsy whereas loss-of-function (LoF) variants are associated with ASD and ID. However, this framework is based on a limited number of functional studies conducted under heterogenous experimental conditions whereas most disease-associated SCN2A variants have not been functionally annotated. We determined the functional properties of more than 30 SCN2A variants using automated patch clamp recording to assess the analytical validity of this approach and to examine whether a binary classification of variant dysfunction is evident in a larger cohort studied under uniform conditions. We studied 28 disease-associated variants and 4 common population variants using two distinct alternatively spliced forms of NaV1.2 that were heterologously expressed in HEK293 T cells. Multiple biophysical parameters were assessed on 5,858 individual cells. We found that automated patch clamp recording provided a valid high throughput method to ascertain detailed functional properties of NaV1.2 variants with concordant findings for a subset of variants that were previously studied using manual patch clamp. Additionally, many epilepsy-associated variants in our study exhibited complex patterns of gain- and loss-of-function properties that are difficult to classify overall by a simple binary scheme. The higher throughput achievable with automated patch clamp enables study of a larger number of variants, greater standardization of recording conditions, freedom from operator bias, and enhanced experimental rigor valuable for accurate assessment of NaV channel variant dysfunction. Together, this approach will enhance our ability to discern relationships between variant channel dysfunction and neurodevelopmental disorders.

Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy.

Gain Of Function Na(V)1.7 Mutations In Idiopathic Small Fiber Neuropathy

Two Novel<i>SCN9A</i>Gene Heterozygous Mutations May Cause Partial Deletion of Pain Perception

Gain-Of-Function Na(V)1.8 Mutations in Painful Neuropathy

N1366S Mutation of Human Skeletal Muscle Sodium Channel Causes Paramyotonia Congenita

The Evolving Landscape of Small Fiber Neuropathy

Exonic mutations in SCN9A (NaV1.7) are found in a minority of patients with erythromelalgia

A New Na(V)1.7 Mutation in an Erythromelalgia Patient

Peripheral temperature dysregulation associated with functionally altered NaV1.8 channels

A Missense Point Mutation in Nerve Growth Factor (NGFR100W) Results in Selective Peripheral Sensory Neuropathy

Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases

Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations

Reduced gray matter volume and cortical thickness in patients with Small-Fiber Neuropathy

Genetic, Electrophysiological, and Pathological Studies on Patients with SCN9A-related Pain Disorders.

A missense point mutation in nerve growth factor (NGF<SUP>R100W</SUP>) results in selective peripheral sensory neuropathy

Gain-of-Function mutations in SCN11A cause familial episodic pain

Painful stimulation increases functional connectivity between supplementary motor area and thalamus in patients with small fibre neuropathy

Identification and In-Silico study of non-synonymous functional SNPs in the human SCN9A gene

Novel SCN9A Missense Mutations Contribute to Congenital Insensitivity to Pain: Unexpected Correlation Between Electrophysiological Characterization and Clinical Phenotype

No Pain, No Gain of Function: Epilepsy-Associated Variants in SCN2A Defy Classification

A Study among the Genotype, Functional Alternations, and Phenotype of 9 SCN1A Mutations in Epilepsy Patients